Wednesday, 29 November, 2023

31 Jan 2021 | Australasian Dental Practice

news > Briefs > Page 8

Is cannabis the antibiotic of tomorrow?

The main nonpsychoactive component of cannabis has been shown to kill the bacteria responsible for gonorrhoea, meningitis and legionnaires disease, which could lead to the first new class of antibiotics for resistant bacteria in 60 years.


The research collaboration between The University of Queensland and Botanix Pharmaceuticals Limited could lead to the first new class of antibiotics for resistant bacteria in 60 years. The UQ Institute for Molecular Bioscience's Associate Professor Mark Blaskovich said CBD - the main nonpsychoactive component of cannabis - can penetrate and kill a wide range of bacteria including Neisseria gonorrhoeae, which causes gonorrhoea. "This is the first time CBD has been shown to kill some types of Gram-negative bacteria. These bacteria have an extra outer membrane, an additional line of defence that makes it harder for antibiotics to penetrate," he said. "We think that cannabidiol kills bacteria by bursting their outer cell membranes, but we don't know yet exactly how it does that and need to do further research".

Management

One Man's Opinion

Techniques

From the editor

Stream the latest dental videos...
VITA CAD/CAM Materials

Sponsored Links...

Upcoming Events...

Nov 24 2023
Dec 06 2023

Kickstarter

Sydney, AUSTRALIA

Jan 08 2024
Feb 13 2024
Mar 12 2024
Mar 13 2024
Mar 21 2024

ADX24 Sydney

Sydney, AUSTRALIA

Apr 16 2024

Dentists Behaving 'Very' Badly

Brisbane, AUSTRALIA

Apr 19 2024

IDEM Singapore 2024

Singapore, SINGAPORE

May 14 2024
May 24 2024
Mar 25 2025

IDS 2025

Cologne, GERMANY

May 08 2025